Quebec's Medicago COVID-19 vaccine approved for use by Health Canada
CTV
The first made-in-Canada COVID-19 vaccine, which is also the first plant-based vaccine, has been officially approved by Health Canada. It's made by Quebec City-based Medicago.
The unique formulation by Quebec City-based Medicago appeared Thursday morning in the federal agency's list of federally approved vaccines. Health Canada is set to give a briefing at 11 a.m.
The company's vaccine is known as Covifenz, and a two-dose regimen has been authorized for use in people aged 18 to 64.
Medicago hasn't yet publicly acknowledged the news or responded to a request for comment on its distribution plans.
It submitted its Phase 3 trial data to federal authorities on Dec. 16. after announcing earlier in the month that its trial had showed good success, with an overall success rate against all variants of 71 per cent, and no adverse reactions.
